Market Approval

Market Approval is mandatory at various milestones in the development of your novel biomedical intervention and need to be passed to move your product to the market and beyond.

Blended learning

Subscribe now or read more about this module below

Signup for 25 Oct 2021

Download the Market Approval brochure

Download brochure

Market Approval

Want to have a look at the way we teach online?

Identify the essential characteristics (claims) of a product

Translate these claims to a product profile and design a market approval strategy

Optimize the market approval process with information from authorities and competitors

Effectuate authority advice meetings

Use market approval to optimize product value

€ 1,600

Non-profit 25% discount

Select

Learn more below or sign-up for this course directly

We understand if you want to have a look at this course. Login or create an account to access a free demo of the online course.

A confirmation email will be sent to new registrations. After completion, you're able to acces the online demo.

Market approval is mandatory at various milestones in the development of your novel biomedical intervention and need to be passed to move your product to the market and beyond. The program focuses on how to guide your biomedical intervention along the milestones of its life cycle in an efficient  and timely manner.

What makes this course special?

The course introduces biomedical professionals to the world of authorities and regulatory affairs. It is interesting for anyone who aims to bring a new medical intervention to market now or in the future. You will learn to identify the product claims that require market approval and how to define a strategy to obtain market approval alongside the developmental program of your product. We will address the authority landscape (e.g. EMA, FDA, Notified bodies, EFSA), legislation, regulatory dossiers, authority advice meetings, product labels and approaches for device-drug combinations and other novel/complex products that require a tailored market approval approach. To deepen your acquired skills, scenarios based on real-world cases are included in exercises to illustrate the complexity and dynamics involved in obtaining and maintaining market approval of biomedical interventions.

What will you learn?

In this 5-week online course, you are introduced to the world of authorities and regulatory affairs for novel medical interventions – medicinal products, medical devices and medical nutrition. You will learn to identify the product

claims that require approval and the way to structure an approach towards authorities to obtain and maintain market approval for your own biomedical research program, institute, or company. Topics that will be addressed are: What are the principles of authority approval procedures? How do you translate the target product characteristics (claims) to a dedicated market approval strategy? In addition, you will learn how to find regulatory information and to deduce the aspects relevant to accelerate the market approval process in pre-approval, market approval and post-approval stages. After completing this course, you will have a clear understanding of the principles behind the market approval system and how to create a strategy to pass the mandatory approvals for your biomedical invention.

5 things you will take away from this course

  1. Identify the essential characteristics (claims) of a product.
  2. translate these claims to a product profile and design a market approval strategy.
  3. optimize the market approval process with information from authorities and competitors.
  4. effectuate authority advice meetings.
  5. use market approval to optimize product value.

I know enough, let's

Market Approval contributors

Market Approval

Juliane Bernholz

Chief Operating Officer


AM Pharma

Market Approval

Onno van de Stolpe

CEO


Galapagos B.V.

Market Approval

Bert Leufkens

Professor of Pharmaceutical Policy and Regulatory Science and Former Chair of Medicines Evaluation Board


Utrecht Institute for Pharmaceutical Sciences (UIPS)

Market Approval

Henk Schuring

VP-Head Rare Nephrology


Sanofi Genzyme

Market Approval

Sjaak Bot

VP, Head of EMEA Regulatory Affairs


Janssen

Market Approval

Bernd van der Meulen

Professor of Comparative Food Law


European Institute for Food Law / Renmin University of China Law School

Market Approval

Eline Bunnik

Assistant professor Medical Ethics and Philosophy of Medicine


Erasmus MC

On-campus

Market Approval

Ineke Jonker-Hoogerkamp

Consultant Regulatory Affairs and Drug Development


Paul Janssen Futurelab & Eagle Pharma Consult

Stay updated about this course